Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia
2018; Springer Nature; Volume: 33; Issue: 1 Linguagem: Inglês
10.1038/s41375-018-0167-0
ISSN1476-5551
AutoresSamir H. Barghout, Parasvi S. Patel, Xiaoming Wang, Guozhou Xu, Simon Kavanagh, Ondrej Halgas, Sara Farshchi Zarabi, Marcela Gronda, Rose Hurren, Danny V. Jeyaraju, Neil MacLean, Shawn Brennan, Marc L. Hyer, Allison Berger, Tary Traore, Michael A. Milhollen, Adam C. Smith, Mark D. Minden, E.F. Pai, Razqallah Hakem, Aaron D. Schimmer,
Tópico(s)Protein Degradation and Inhibitors
Referência(s)